{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:36:49Z","timestamp":1761849409060,"version":"build-2065373602"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T00:00:00Z","timestamp":1747958400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04569-0","type":"journal-article","created":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T06:29:46Z","timestamp":1747981786000},"page":"4013-4018","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Efficacy of adjuvant amikacin combined with oral levofloxacin as prophylaxis for transrectal prostate biopsy in patients harboring fluoroquinolone-resistant Escherichia coli in rectal flora"],"prefix":"10.1007","volume":"57","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9338-8750","authenticated-orcid":false,"given":"Yoshitsugu","family":"Nasu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masanori","family":"Hanamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryota","family":"Fujisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daisuke","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Kosaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,23]]},"reference":[{"key":"4569_CR1","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/JU.0000000000000814","volume":"204","author":"A Pilatz","year":"2020","unstructured":"Pilatz A, Dimitropoulos K, Veeratterapillay R, Yuan Y, Omar MI, MacLennan S, Cai T, Bruyere F, Bartoletti R, Koves B, Wagenlehner F, Bonekat G, Pradere B (2020) Antibiotic prophylaxis for thr prevention of infectious complications following prostate biopsy: a systemativ review and meta-analysis. J Urol 204:224\u2013230. https:\/\/doi.org\/10.1097\/JU.0000000000000814","journal-title":"J Urol"},{"key":"4569_CR2","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.juro.2011.06.057","volume":"186","author":"S Loeb","year":"2011","unstructured":"Loeb S, Carter HB, Berndt SI, Ricker W, Schaeffer EM (2011) Complications after prostate biopsy: data from SEER-Medicare. J Urol 186:1830\u20131834. https:\/\/doi.org\/10.1016\/j.juro.2011.06.057","journal-title":"J Urol"},{"key":"4569_CR3","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.urology.2019.12.023","volume":"138","author":"JE Shoag","year":"2020","unstructured":"Shoag JE, Gaffney C, Pantuck M, Sun T, Gorin M, Schaeffer E, Sedrakyan A, Vicers A, Hu J (2020) Risk factor for infection after prostate biopsy in the United State. Urology 138:113\u2013118. https:\/\/doi.org\/10.1016\/j.urology.2019.12.023","journal-title":"Urology"},{"key":"4569_CR4","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1111\/bju.15713","volume":"130","author":"O Ljungquist","year":"2022","unstructured":"Ljungquist O, Persmark A, Grabe M, Jakobsen AK, Gerdtsson A, Torisson G, Bjartell A, Riesbeck K (2022) Increasing rates of urinary and bloodstream infections following transrectal prostate biopsy in south Sweden. BJU Int 130:478\u2013485. https:\/\/doi.org\/10.1111\/bju.15713","journal-title":"BJU Int"},{"key":"4569_CR5","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1016\/j.juro.2011.1.115","volume":"187","author":"AK Taylor","year":"2012","unstructured":"Taylor AK, Zembower TR, Nadler RB, Scheetz MH, Cashy JP, Bowen D, Murphy AB, Dielubanza E, Schaeffer AJ (2012) Targeted antimicrobial prophylaxis using rectal swab cultures in men undergoing transrectal ultrasound guided prostate biopsy in associated with reduced incidence of postoperative infectious complicaions and cost of care. J Urol 187:1275\u20131279. https:\/\/doi.org\/10.1016\/j.juro.2011.1.115","journal-title":"J Urol"},{"key":"4569_CR6","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1111\/j.1464-410X.2010.09715.x","volume":"107","author":"D Batura","year":"2010","unstructured":"Batura D, Rao GG, Nielsen PB, Charlett A (2010) Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int 107:760\u2013764. https:\/\/doi.org\/10.1111\/j.1464-410X.2010.09715.x","journal-title":"BJU Int"},{"key":"4569_CR7","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.jurol.2012.08.237","volume":"189","author":"EO Kehinde","year":"2013","unstructured":"Kehinde EO, Al-Maghrebi M, Sheikh M, Anim T (2013) Combined ciprofloxacin and amikacin prophylaxis in the prevention of septicemia after transrectal ultrasound guided biopsy of the prostate. J Urol 189:911\u2013915. https:\/\/doi.org\/10.1016\/j.jurol.2012.08.237","journal-title":"J Urol"},{"key":"4569_CR8","first-page":"583","volume":"89","author":"Y Nasu","year":"2015","unstructured":"Nasu Y, Sako S, Yano T, Kosaka N (2015) Surveillance of antimicrobial resistant Escherichia coli by rectal swab method-annual change of prevalence of quinolone-resistant and ESBL producing strains from 2009 to 2013. J Jpn Assoc Infect Dis 89:583\u2013587","journal-title":"J Jpn Assoc Infect Dis"},{"key":"4569_CR9","doi-asserted-by":"publisher","first-page":"2199","DOI":"10.1016\/S0022-5347(01)64716-5","volume":"157","author":"PR Sieber","year":"1997","unstructured":"Sieber PR, Rommel FM, Agusta VE, Breslin JA, Huffnagle HW, Harpster LE (1997) Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol 157:2199\u20132200","journal-title":"J Urol"},{"key":"4569_CR10","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/j.1464-410X.2008.07554.07556.x","volume":"101","author":"HP Burden","year":"2008","unstructured":"Burden HP, Ranasinghe W, Persad R (2008) Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practicing evidence-based medicine? BJU Int 101:1202\u20131204. https:\/\/doi.org\/10.1111\/j.1464-410X.2008.07554.07556.x","journal-title":"BJU Int"},{"key":"4569_CR11","doi-asserted-by":"publisher","first-page":"1673","DOI":"10.1016\/j.juro.2014.06.005","volume":"192","author":"MA Liss","year":"2014","unstructured":"Liss MA, Taylor SA, Batura D, Steensels D, Chakulkeeree M, Soenens C, Rao GG, Dash A, Park S, Patel N, Woo J, McDonald M, Nseyo U, Banapour P, Unterberg S, Ahlering TE, Poppel HV, Sakamoto K, Fierer J, Black PC (2014) Fluoroquinolone resistant rectal colonization predicts risk of infectious complications after transrectal prostate biopsy. J Urol 192:1673\u20131678. https:\/\/doi.org\/10.1016\/j.juro.2014.06.005","journal-title":"J Urol"},{"key":"4569_CR12","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/iju.13960","volume":"26","author":"Y Hiyama","year":"2019","unstructured":"Hiyama Y, Takahashi S, Uehara T, Ichihara K, Hashimoto J, Matsukawa M, Taguchi K, Kunishima Y, Hotta H, Yanase M, Itoh N, Hirose T, Takayama K, Tachiki H, Masumori N (2019) Selective culture of Escherichia coli to prevent infective complications of trans ultrasound-guided prostate biopsy: clinical efficacy and analysis of characteristics of quinoione-resistant Escherichia coli. Int J Urol 26:655\u2013660. https:\/\/doi.org\/10.1111\/iju.13960","journal-title":"Int J Urol"},{"key":"4569_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2024.12.018","author":"T Sadahira","year":"2025","unstructured":"Sadahira T, Sekito T, Maruyama Y, Ichikawa T, Kurihara Y, Shiraishi H, Sakuma T, Tokunaga M, Mitsui Y, Kusumi N, Tominaga Y, Katayama S, Iwata T, Nishimura S, Edamura K, Kobayashi T, Watanabe M, Hiyama Y, Yamada H, Kurata H, Kondo T, Mitsui M, Takenaka T, Kiyota H, Araki M, Miyazaki J, Takahashi A, Yamamoto S, Wada K (2025) Significance of targeted antimicrobial prophylaxis using rectal-culture selective screening media prior to transrectal prostate biopsy: a multicenter, randomized controlled trial. Urology. https:\/\/doi.org\/10.1016\/j.urology.2024.12.018","journal-title":"Urology"},{"key":"4569_CR14","first-page":"283","volume":"49","author":"M Kishi","year":"1987","unstructured":"Kishi M, Nasu Y, Mizuno A, Miyata K, Kumon H, Ohmori H, Nanba K, Yasuhiro Y, Akaeda T, Takamoto H (1987) Prostatic tissue and fluid levels of amikacin and gentamicin. Nishinihon J Urol 49:283\u2013288","journal-title":"Nishinihon J Urol"},{"key":"4569_CR15","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1442-2042.1998.tb00597.x","volume":"5","author":"T Goto","year":"1998","unstructured":"Goto T, Makinose S, Ohi Y, Yamauchi D, Kayajima T, Nagayama K, Hayami H (1998) Diffusion of piperacillin, cefotiam, minocycline, amikacin and ofloxacin into the prostate. Int J Urol 5:243\u2013246","journal-title":"Int J Urol"},{"key":"4569_CR16","first-page":"51","volume":"15","author":"Y Matstuki","year":"2013","unstructured":"Matstuki Y, Tsukamoto T, Hosoyamada M, Watanabe T, Watanabe S, Tsuchiya M (2013) Study of efficacy on the administration of 400 mg of amikacin sulfete administered once daily to elderly patients. Jpn J Drug Inform. 15:51\u201356","journal-title":"Jpn J Drug Inform."},{"key":"4569_CR17","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1179\/joc.2005.17.1.46","volume":"17","author":"L Drago","year":"2005","unstructured":"Drago L, Vecchi ED, Nicola L, Legnani D, Lombardi A, Gismondo MR (2005) In vitro synergy and selection of resistance by fluoroquinolones plus amikacin or \u03b2-lactams against extended-spectrum \u03b2-lactamase-producing Escherichia coli. J Chemother 17:46\u201353","journal-title":"J Chemother"},{"key":"4569_CR18","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2018.33.e113","volume":"33","author":"KC Son","year":"2018","unstructured":"Son KC, Chung HS, Jung SI, Kim MS, Hwang EC, Kim JW, Kwon DD (2018) Trial comparing a combined regimen of amikacin and ciprofloxacin to ciprofloxacin alone as transrectal prostate biopsy prophylaxis in the era of high fluoroquinolone-resistant rectal flora. J Korean Med Sci 33:e113. https:\/\/doi.org\/10.3346\/jkms.2018.33.e113","journal-title":"J Korean Med Sci"},{"key":"4569_CR19","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1590\/S1677-5538.IBJU.2016.0619","volume":"43","author":"E Kisa","year":"2017","unstructured":"Kisa E, Altug MU, Gurbus OA, Ozdemir H (2017) Fosfomycin: a good alternative drug for prostate biopsy prophylaxis the results of prospective, respects to risk factors. Int Braz J Urol 43:1068\u20131074. https:\/\/doi.org\/10.1590\/S1677-5538.IBJU.2016.0619","journal-title":"Int Braz J Urol"},{"key":"4569_CR20","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1111\/iju.13883","volume":"26","author":"JV Besien","year":"2019","unstructured":"Besien JV, Uvim P, Weyne E, Ptaet CV, Merckx L, Graeve ND, Renterghem KV, Cartuyvels R, Abeele AMV (2019) Use of Fosfomycin as targeted antibiotic prophylaxis before prostate biopsy: a prospective study. Int J Urol 26:391\u2013397. https:\/\/doi.org\/10.1111\/iju.13883","journal-title":"Int J Urol"},{"key":"4569_CR21","doi-asserted-by":"publisher","first-page":"911","DOI":"10.3390\/medicina59050911","volume":"59","author":"HM Gu","year":"2023","unstructured":"Gu HM, Gu JS, Chung HS, Jung SI, Kwon D, Kim MH, Jung JH, Han MA, Kang SJ, Hwang EC, Dahm P (2023) Fosfomycin for antibiotic prophylaxis in men undergoing a transrectal prostate biopsy: a systematic review and meta-analysis. Medicina 59:911. https:\/\/doi.org\/10.3390\/medicina59050911","journal-title":"Medicina"},{"key":"4569_CR22","unstructured":"EAU guideline 2024. https:\/\/uroweb.org\/guidlines\/prostate-cancer\/chapter\/diagnostic-evaluation"},{"key":"4569_CR23","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1038\/s43856-023-00337-2","volume":"3","author":"V Tchesnokova","year":"2023","unstructured":"Tchesnokova V, Larson L, Basova I, Sledneva Y, Choudhury D, Solyanik T, Heng J, Bonilla TC, Pham S, Schartz EM, Madziwa LT, Holden E, Weissman SJ, Ralston JD, Sokurenko EV (2023) Increase in the community circulation of ciprofloxacin-resistant Escherichia coli despite reduction in antibiotic prescriptions. Commun Med 3:110. https:\/\/doi.org\/10.1038\/s43856-023-00337-2","journal-title":"Commun Med"},{"key":"4569_CR24","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1007\/s00345-016-1985-1","volume":"35","author":"L Pepdjonovic","year":"2017","unstructured":"Pepdjonovic L, Tan GH, Huang S, Mann S, Frydenberg M, Moon D, Hanegbi U, Landau A, Snow R, Grummet J (2017) Zero hospital admissions for infection after 577 transperineal prostate biopsies using single-dose cefazolin prophylaxis. World J Urol 35:1199\u20131203. https:\/\/doi.org\/10.1007\/s00345-016-1985-1","journal-title":"World J Urol"},{"key":"4569_CR25","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.1001\/jamaoncol.2024.4000","volume":"10","author":"JC Hu","year":"2024","unstructured":"Hu JC, Assel M, Allaf MA, Vickers AJ, Ehdaie B, Cohen AJ, Green DA, Ghazi A, Ristau BT, Kowalczyk KJ, George AK, Patel HD, Montgomery JS, Han M, Rezaee M, Pavlovich CP, Patel NA, Ross AE, Kundu SD, Wang GJ, Shoag JE, Singla N, Stensland K, Gorin MA, Schaeffer AJ, Schaeffer EM (2024) Transperieal vs transrectal prostate biopsy\u2014the PREVENT randomized clinical traial. JAMA Oncol 10:1590\u20131593. https:\/\/doi.org\/10.1001\/jamaoncol.2024.4000","journal-title":"JAMA Oncol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04569-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04569-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04569-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:15:25Z","timestamp":1761848125000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04569-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,23]]},"references-count":25,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4569"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04569-0","relation":{},"ISSN":["1573-2584"],"issn-type":[{"type":"electronic","value":"1573-2584"}],"subject":[],"published":{"date-parts":[[2025,5,23]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}